v3.26.1
Stockholders' Deficit (Tables)
 3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Share-based Compensation, Stock Options, Activity
The following table summarizes all option activity for the three months ended March 31, 2026:
OptionsWeighted Average Exercise PriceWeighted Average Remaining Contractual Life (years)Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 20256,859,321 $7.21 5.56$11 
  Exercised(19,500)6.64 5 
  Forfeited and expired(87,384)8.76 
Outstanding at March 31, 20266,752,437 $7.19 5.32$19 
Exercisable at March 31, 20264,833,704 $7.01 4.84$19 
Schedule of Nonvested Restricted Stock Shares Activity
The following table summarizes restricted stock activity for the three months ended March 31, 2026:

Number of SharesWeighted Average Fair Value
Non-vested balance at January 1, 2026138,235$9.06 
  Shares granted140,911 5.52 
  Shares vested(89,179)8.73 
Non-vested balance at March 31, 2026189,967$6.60 
The following table summarizes restricted stock unit activity for the three months ended March 31, 2026:

Number of SharesWeighted Average Fair Value
Non-vested balance at January 1, 20261,120,393$7.29 
  Shares granted - service conditions529,142 5.39 
  Shares granted - market conditions890,030 5.41 
  Bonus shares granted506,244 5.36 
  Shares vested(941,232)5.79 
  Shares canceled - market conditions(218,543)4.21 
Non-vested balance at March 31, 20261,886,034$5.32 
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award The stock units contain market conditions
whereby the stock units will vest subject to the achievement of a specified VWAP, subject to continued employment or service through the end of the performance period as observed and summarized below:

VWAP over a period of 20 consecutive trading days of the three-year performance period
VWAPNumber of Shares that Vest
$6.49216,990
$7.57289,054
$8.66383,986
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions The below table summarizes the assumptions used to estimate the fair value of the restricted stock units granted:
Monte Carlo Model
Expected volatility41.3%
Risk free interest rate3.59%
Expected dividend yield14.7%